Please assess the completion status of the following clinical trial:

Trial Title: Role of Suppression of Endometriosis With Progestins Before IVF-ET

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed diagnosis of endometriosis~* body mass index \< 35 Kg/m2~Exclusion Criteria:~* if they have been already on long-term down-regulation of the pituitary gland with GnRHa for control of endometriosis~* liver or kidney disease~* evidence of diminished ovarian reserve (e.g. high FSH level \>12 IU/L or low AMH level \<1 ng/ml).

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Dienogest (Type: ACTIVE_COMPARATOR): None
- GnRH analogue (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).